Press Room (Corporate News) https://www.news.sanofi.us/ MediaRoom Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID® https://www.news.sanofi.us/2026-10-02-Sanofi-and-2026-NBA-Champion-Karl-Anthony-Towns-team-up-to-raise-awareness-of-COVID-19-vaccination-with-NUVAXOVID-R Fri, 02 Oct 2026 11:57:00 -0400 https://www.news.sanofi.us/2026-10-02-Sanofi-and-2026-NBA-Champion-Karl-Anthony-Towns-team-up-to-raise-awareness-of-COVID-19-vaccination-with-NUVAXOVID-R Sanofi partners with USA Pickleball to launch “Serve Up Protection” campaign to help protect older adults from COVID-19 with NUVAXOVID™ https://www.news.sanofi.us/2026-09-09-Sanofi-partners-with-USA-Pickleball-to-launch-Serve-Up-Protection-campaign-to-help-protect-older-adults-from-COVID-19-with-NUVAXOVID-TM Thu, 10 Sep 2026 09:00:00 -0400 https://www.news.sanofi.us/2026-09-09-Sanofi-partners-with-USA-Pickleball-to-launch-Serve-Up-Protection-campaign-to-help-protect-older-adults-from-COVID-19-with-NUVAXOVID-TM Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS® https://www.news.sanofi.us/2026-09-08-Sanofi-and-Keke-Palmer-team-up-to-urge-parents-to-help-protect-babies-from-serious-RSV-with-BEYFORTUS-R Tue, 08 Sep 2026 08:00:00 -0400 https://www.news.sanofi.us/2026-09-08-Sanofi-and-Keke-Palmer-team-up-to-urge-parents-to-help-protect-babies-from-serious-RSV-with-BEYFORTUS-R Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector https://www.news.sanofi.us/2026-07-10-Sanofis-subcutaneous-Sarclisa-Escena-approved-in-the-US-as-first-anticancer-treatment-administered-via-on-body-injector Fri, 10 Jul 2026 10:27:00 -0400 https://www.news.sanofi.us/2026-07-10-Sanofis-subcutaneous-Sarclisa-Escena-approved-in-the-US-as-first-anticancer-treatment-administered-via-on-body-injector Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes https://www.news.sanofi.us/2026-06-12-Sanofis-Tzield-approved-in-the-US-as-the-first-disease-modifying-therapy-for-patients-recently-diagnosed-with-stage-3-type-1-diabetes Fri, 12 Jun 2026 19:29:00 -0400 https://www.news.sanofi.us/2026-06-12-Sanofis-Tzield-approved-in-the-US-as-the-first-disease-modifying-therapy-for-patients-recently-diagnosed-with-stage-3-type-1-diabetes